ATE143806T1 - Verbesserungen von oder in bezug auf exzitatorische aminosäurenrezeptorantagonisten - Google Patents

Verbesserungen von oder in bezug auf exzitatorische aminosäurenrezeptorantagonisten

Info

Publication number
ATE143806T1
ATE143806T1 AT92304887T AT92304887T ATE143806T1 AT E143806 T1 ATE143806 T1 AT E143806T1 AT 92304887 T AT92304887 T AT 92304887T AT 92304887 T AT92304887 T AT 92304887T AT E143806 T1 ATE143806 T1 AT E143806T1
Authority
AT
Austria
Prior art keywords
eaa
amino acid
acid receptor
receptor antagonists
excitatory amino
Prior art date
Application number
AT92304887T
Other languages
English (en)
Inventor
Loretta Ames Mcquaid
Charles Howard Mitch
Paul Leslie Ornstein
Darryle Darwin Schoepp
Edward C R Smith
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE143806T1 publication Critical patent/ATE143806T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT92304887T 1991-06-05 1992-05-29 Verbesserungen von oder in bezug auf exzitatorische aminosäurenrezeptorantagonisten ATE143806T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/710,649 US5153196A (en) 1991-06-05 1991-06-05 Excitatory amino acid receptor antagonists and methods for the use thereof

Publications (1)

Publication Number Publication Date
ATE143806T1 true ATE143806T1 (de) 1996-10-15

Family

ID=24854947

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92304887T ATE143806T1 (de) 1991-06-05 1992-05-29 Verbesserungen von oder in bezug auf exzitatorische aminosäurenrezeptorantagonisten

Country Status (9)

Country Link
US (1) US5153196A (de)
EP (1) EP0518530B1 (de)
JP (1) JPH05163147A (de)
AT (1) ATE143806T1 (de)
CA (1) CA2070055A1 (de)
DE (1) DE69214358T2 (de)
DK (1) DK0518530T3 (de)
ES (1) ES2092639T3 (de)
GR (1) GR3021874T3 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4241563A1 (de) * 1992-12-10 1994-06-16 Basf Ag Neue Triazolochinazoline, ihre Herstellung und Verwendung
DE4241562A1 (de) * 1992-12-10 1994-06-16 Basf Ag Neue Triazolopyrimidone, ihre Herstellung und Verwendung
DE4241564A1 (de) * 1992-12-10 1994-06-16 Basf Ag Triazolochinazoline zur Behandlung zentralnervöser Erkrankungen
DK31093D0 (de) * 1993-03-19 1993-03-19 Novo Nordisk As
FI954614L (fi) * 1993-03-31 1995-09-28 Basf Ag Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina
DE4310523A1 (de) * 1993-03-31 1994-10-06 Basf Ag Imidazolo-chinoxalinone zur Behandlung zentralnervöser Erkrankungen
IL110309A0 (en) * 1993-07-15 1994-10-21 Univ Kentucky Res Found A method of protecting against neuron loss
FR2707643B1 (fr) * 1993-07-16 1995-08-11 Rhone Poulenc Rorer Sa Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.
KR970701192A (ko) * 1994-02-11 1997-03-17 안네 섹커 헤테로사이클릭 화합물, 및 이의 제조방법 및 용도(Heterocyclic compounds and their preparation and use)
FR2717814B1 (fr) * 1994-03-28 1996-04-26 Rhone Poulenc Rorer Sa Dérivés de 1,2,4-triazolo(4,3-a)pyrazine-4-one, leur préparation et les médicaments les contenant.
FR2717813B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés d'imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant .
FR2717805B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant .
FR2717811B1 (fr) * 1994-03-28 1996-04-26 Rhone Poulenc Rorer Sa Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.
FR2717812B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant.
CA2200055A1 (en) * 1994-09-16 1996-03-21 Novo Nordisk A/S [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
CZ284930B6 (cs) * 1994-09-16 1999-04-14 Novo Nordisk A/S [1,2,4]triazolo[4,3-a]chinoxalinonové deriváty, jejich příprava a použití
CA2200358A1 (en) * 1994-09-30 1996-04-11 Hans-Jorg Treiber New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
DE19510965A1 (de) * 1995-03-24 1996-09-26 Asta Medica Ag Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
US6869956B2 (en) * 2000-10-03 2005-03-22 Bristol-Myers Squibb Company Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
ATE319713T1 (de) * 2000-10-03 2006-03-15 Bristol Myers Squibb Co Amino- substituierte tetracyclische verbindungen die als entzündungshemmende mittel nützlich sind, und diese enthaltende arzneimittel.
WO2006074281A2 (en) * 2005-01-06 2006-07-13 Merck & Co., Inc. Inhibitors of checkpoint kinases
US7485649B2 (en) * 2005-01-06 2009-02-03 Merck & Co., Inc. Inhibitors of checkpoint kinases
WO2008072779A1 (ja) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. キノキサリン誘導体
KR101168235B1 (ko) 2010-06-16 2012-07-30 건국대학교 산학협력단 ４?클로로테트라졸로［１，５?ａ］퀴녹살린 및 그 유도체를 유효성분으로 함유하는 알레르기성 질환의 예방 및 치료용 조성물
US9540379B2 (en) * 2011-01-31 2017-01-10 Boehringer Ingelheim International Gmbh (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
US9617031B1 (en) * 2015-02-13 2017-04-11 Carol Jean Piechocinski Foldable liquid retaining bowl
US9701435B2 (en) 2015-02-13 2017-07-11 Carol Jean Piechocinski Foldable liquid retaining bowl

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764681A (en) * 1970-07-08 1973-10-09 Lilly Co Eli Certain tetrazolo-(1,5-a) quinoline compounds as fungus control agents
US3953457A (en) * 1972-07-28 1976-04-27 Eli Lilly And Company Agent for the control of plant-pathogenic organisms
US4008322A (en) * 1975-06-10 1977-02-15 Eli Lilly And Company Triazolo(4,3-a)quinoxalines for control of rice
US3979387A (en) * 1975-06-10 1976-09-07 Eli Lilly And Company 4,5-Dihydrotetrazolo(1,5-A)quinoxalines
US3987196A (en) * 1975-06-10 1976-10-19 Eli Lilly And Company Tetrazolo(1,5-a)quinoxalines for control of phytopathogens
US4128644A (en) * 1977-07-29 1978-12-05 E. R. Squibb & Sons, Inc. Pyrazolo(1,5-c)quinazoline derivatives and related compounds
US4354027A (en) * 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
US4495187A (en) * 1982-10-18 1985-01-22 Pfizer Inc. Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents
US4623725A (en) * 1982-10-18 1986-11-18 Pfizer Inc. [1,2,4]Triazolo[4,3-a]quinoxaline-4-amine derivatives
US4713383A (en) * 1984-10-01 1987-12-15 Ciba-Geigy Corporation Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
US4968678A (en) * 1988-02-19 1990-11-06 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists
DK161148C (da) * 1988-06-14 1991-11-18 Novo Nordisk As Imidazoquinoxalinforbindelser, fremgangsmaade til fremstilling deraf samt farmaceutiske praeprater indeholdende forbindelserne
DK160941C (da) * 1988-06-28 1991-10-21 Novo Nordisk As Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists

Also Published As

Publication number Publication date
CA2070055A1 (en) 1992-12-06
GR3021874T3 (en) 1997-03-31
EP0518530A3 (en) 1993-01-20
EP0518530B1 (de) 1996-10-09
US5153196A (en) 1992-10-06
EP0518530A2 (de) 1992-12-16
DE69214358D1 (de) 1996-11-14
ES2092639T3 (es) 1996-12-01
DE69214358T2 (de) 1997-03-06
DK0518530T3 (da) 1997-03-17
JPH05163147A (ja) 1993-06-29

Similar Documents

Publication Publication Date Title
DE69214358D1 (de) Verbesserungen von oder in Bezug auf exzitatorische Aminosäurenrezeptorantagonisten
CY1107401T1 (el) Παραγωγα βενζοθειαζολιου πα την θεραπευτικη αντιμετωπιση της νοσου alzheimer και της νοσου parkinson
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
ATE139233T1 (de) Annelierte thiophen-derivate, ihre herstellung und verwendung
DK0675886T3 (da) Aminomethylensubstituerede ikke-aromatiske heterocykler og deres anvendelse som substance P-antagonister
DE69906492D1 (de) Fluorhaltige aminosäurederivate
DE60211343D1 (de) Derivate von triazolyl-imidazopyridine und von triazolylpurine als ligande des adenosine a2a rezeptoren und ihre verwendung als medicamente
NO942452D0 (no) Amid- og ureaderivater med antihyperkolesteremisk aktivitet, deres fremstilling og terapeutiske anvendelser
NO931317L (no) Et terapeutisk middel for parkinson's sykdom
JO2321B1 (en) 4-phenyl-pyridine derivatives
NZ238956A (en) 3-arylindole or 3-arylindazole derivatives and medicaments thereof.
ATE220399T1 (de) Neue naphthamid-derivate und ihre therapeutische verwendung als d3-rezeptor agonisten
DK0676397T3 (da) Oxypyridinylquinoxalinderivater
CA2388470A1 (en) Use of carbonylamino derivatives against cns disorders
DE69030665D1 (de) (1,2n) und (3,2n)-karbozyklische-2-amino-tetralinderivate
DE502004007387D1 (de) Triazolverbindungen und ihre therapeutische verwendung
AR021094A1 (es) Compuestos heterociclicos inhibidores de la fosfodiesterasa iv y su uso para el tratamiento de enfermedades inflamatorias
PT896822E (pt) 4-aminopirrolo (3,2-d)pirimidinas como antagonistas do receptor de neuropeptideo y
DE69110219D1 (de) 3-(1H-Indazol-3-yl)-4-pyridiname, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
AR016672A1 (es) Ligandos del receptor h3 del tipo fenil-alquil-imidazoles, composicion farmaceutica que los contiene y el uso de los mismos para la manufactura de unmedicamento
FI943875A0 (fi) 2,3,4,5-Tetrahydro-1H-3-bentsatsepiinejä ja niiden farmaseuttisesti hyväksyttäviä happoadditiosuoloja
EP0802179A4 (de) Derivate substituierter amidinonaphthylester
ATE198750T1 (de) Isatinoxim-derivate, ihre herstellung und verwendung
DE69320542D1 (de) Pyrrolothienopyrazin-Verbindungen als 5HT3-Rezeptoren-Antagonisten
DE69002217D1 (de) Dibenzodioxazecin- und dibenzodioxaazacycloundecin-derivate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee